Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Andreas S. Buser, MD, Laura Infanti, MD, Andreas Holbro, MD, Joerg Halter, MD, Sabine Gerull, MD, Dominik Heim, MD, Michael Medinger, MD, Dimitrios A. Tsakiris, MD, Johannes Irsch, PhD, Jin-Sying Lin, PhD, Richard J. Benjamin, MD, Laurence Corash, MD, Jakob R. Passweg, MD

Blood (2019) 134 (Supplement_1): 1167.

https://doi.org/10.1182/blood-2019-122330

Published: 2019

Journal Articles

Red Blood Cell Allo-Antibodies after Allogeneic Hematopoietic Stem Cell Transplantation

Astrid Beerlage, MD, Joerg Halter, MD, Sabine Gerull, MD, Michael Medinger, MD, Tanja Ruefli, Georg Stussi, MD, Dominik Heim, MD, Beatrice Drexler, MD, Laura Infanti, MD, Andreas Holbro, MD, Jakob R. Passweg, MDMS, Andreas S. Buser, MD

Blood (2018) 132 (Supplement 1): 2551.

https://doi.org/10.1182/blood-2018-99-116237

Published: 2018

Journal Articles

Molecular Risk Stratification Predicts Engraftment Latency of Human Acute Myeloid Leukemia Cells Transplanted in NOD/SCID/IL-2Rgc-Null Mice

Anna M Paczulla, M.Sc., Stephan Dirnhofer, Martina Konantz, PhD, Michael Medinger, MD, Helmut R. Salih, MD, Kathrin Rothfelder, MSc, Jakob Passweg, MD, Dimitrios Tsakiris, Pontus Lundberg, PhD, Claudia Lengerke, MD

Blood (2016) 128 (22): 2867.

https://doi.org/10.1182/blood.V128.22.2867.2867

Published: 2016

Journal Articles

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Federico Simonetta, MD PhD, Hélène Labussière-Wallet, MD, Maciej J Machaczka, MD, Flore Sicre de Fontbrune, MD, Michael Medinger, MD, Sylvain Chantepie, MD, Tony Marchand, MD, Stavroula Masouridi-Levrat, MD, Marie-Thérèse Rubio, MD PhD, Oumedaly Reman, MD, Nathalie Dhedin, MD, Loic Fouillard, MD, Olivier Lambotte, MD PhD, Lionel Galicier, MD, Paul Coppo, MD PhD, Jakob Passweg, MD, Ibrahim Yakoub-Agha, MD PhD, Regis Peffault De Latour, MD PhD, Yves Chalandon, MD

Blood (2016) 128 (22): 4617.

https://doi.org/10.1182/blood.V128.22.4617.4617

Published: 2016

Journal Articles

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Sabine Gerull, MD, Andreas S Buser, MD, Christoph Bucher, MD, Dominik Heim, MD, Michael Medinger, MD, Jakob Passweg, MD, Martin Stern, MD

Blood (2013) 122 (21): 5456.

https://doi.org/10.1182/blood.V122.21.5456.5456

Published: 2013

Journal Articles

Intra-Arterial Catheter Guided Steroid Administration For The Treatment Of Steroid-Refractory Intestinal GvHD

Michael Medinger, MD, David Buergler, MD, Jakob Passweg, MD, Arne Fischmann, MD, Christoph Bucher, MD

Blood (2013) 122 (21): 4604.

https://doi.org/10.1182/blood.V122.21.4604.4604

Published: 2013

Journal Articles

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Alicia Rovo, MD, Thomas Daikeler, MD, Joerg Halter, MD, Dominik Heim, MD, Jan Dirk Studt, MD, Michael Medinger, MD, Caroline Arber, MD, Martin Stern, MD, Dimitrios Tsakiris, MD, Alan Tyndall, MD, Alois Gratwohl, MD, Andre Tichelli, MD

Blood (2008) 112 (11): 4298.

https://doi.org/10.1182/blood.V112.11.4298.4298

Published: 2008

Journal Articles

Chronic GVHD Leads to Shortening of Telomeres in Subsets of Lymphoid Cells but Not in Granulocytes in Long-Term Survivors after Allogeneic HSCT.

Gabriela M. Baerlocher, MD, Alicia Rovo, MD, Sybille Matthey, PhD, Astrid Mueller, PhD, Thomas Daikeler, MD, Michael Medinger, MD, Jörg Halter, MD, Dominik Heim, MD, Alois Gratwohl, MD, Andre Tichelli, MD

Blood (2006) 108 (11): 2872.

https://doi.org/10.1182/blood.V108.11.2872.2872

Published: 2006

NARROW

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Red Blood Cell Allo-Antibodies after Allogeneic Hematopoietic Stem Cell Transplantation

Molecular Risk Stratification Predicts Engraftment Latency of Human Acute Myeloid Leukemia Cells Transplanted in NOD/SCID/IL-2Rgc-Null Mice

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Intra-Arterial Catheter Guided Steroid Administration For The Treatment Of Steroid-Refractory Intestinal GvHD

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Chronic GVHD Leads to Shortening of Telomeres in Subsets of Lymphoid Cells but Not in Granulocytes in Long-Term Survivors after Allogeneic HSCT.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only